EUVIMEDUpptäck EUVIMED
Open access · CC BY 4.0

Integrated Ultrasound Features, Cytologic Subclassification, and Systemic Inflammatory Markers for Predicting Malignancy in Bethesda III Thyroid Nodules

Emine Yildirim iD, Pelin Cobanoglu Akbas iD, Sibel Bektas iD, Adem Senturk iD, Pelin Basım iD, Umut Fırat Turan iD, Nesimi Mecit iD, Hanifi Onalan iD, Hafize Uzun iD, Mustafa Uygar Kalaycı iD

Journal of Clinical Medicine · 2026-08-18 · 15 (16) · 6375

DOI: 10.3390/jcm15166375 ↗

At a glance

Journal article in Journal of Clinical Medicine, published online on 2026-08-18. Written by Emine Yildirim and 9 co-authors. Institution: Department of General Surgery, Faculty of Medicine, Atlas University, 34403 Istanbul, Türkiye. 19 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiska uppgifterCiteRelated studies

Abstract (original language)

Background/Objectives: Bethesda category III (atypia of undetermined significance/follicular lesion of undetermined significance; AUS/FLUS) thyroid nodules represent a heterogeneous group with variable malignancy risk, creating challenges in clinical management. This study aimed to evaluate the associations of preoperative ultrasonographic findings, inflammation-based hematological markers, and cytological atypia subtypes with final histopathological outcomes in surgically treated Bethesda III thyroid nodules.

Methods

This retrospective study included 72 adult patients with Bethesda III thyroid nodules who underwent thyroid surgery between January 2020 and December 2025. Demographic characteristics, ultrasonographic findings, neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), cytological atypia subtypes, and final histopathological diagnoses were analyzed. Univariate and multivariable logistic regression analyses were performed to identify predictors of malignancy.

Results

Final histopathological examination revealed benign lesions in 49 patients (68.1%) and malignant lesions in 23 patients (31.9%). Age, sex, nodule size, multinodular goiter, Hashimoto thyroiditis, microcalcifications, hypoechogenicity, suspicious margins, and TI-RADS category were not significantly associated with malignancy (all p > 0.05). Similarly, NLR and PLR did not differ significantly between benign and malignant nodules (NLR: 1.80 vs. 1.98, p = 0.319; PLR: 117.9 vs. 135.0, p = 0.398). Among cytological atypia subtypes, nuclear atypia demonstrated the highest malignancy rate (50.0%) and was significantly associated with malignant histopathological outcomes (OR = 3.364, 95% CI: 1.182–9.570, p = 0.023). After adjustment for age and biopsied nodule size, nuclear atypia remained an independent predictor of malignancy (adjusted OR = 3.963, 95% CI: 1.298–12.094, p = 0.016).

Conclusions

In surgically treated Bethesda III thyroid nodules, nuclear atypia was the only independent predictor of malignancy, whereas ultrasonographic characteristics, NLR, and PLR showed limited predictive value. Subclassification of Bethesda III nodules according to cytological atypia may improve preoperative risk stratification and support clinical decision-making. Because the study included only surgically treated patients, the findings should be interpreted in the context of a surgically selected cohort and may not be generalizable to the overall Bethesda III population.

Subjects

Author keywords

AUS/FLUSBethesda IIImalignancy risknuclear atypiathyroid noduleultrasonography

Authors and institutions

  • Department of General Surgery, Faculty of Medicine, Atlas University, 34403 Istanbul, Türkiye.
  • Department of Pathology, Gaziosmanpaşa Training and Research Hospital, University of Health Sciences, 34255 Istanbul, Türkiye.
  • Department of Oncologic Surgery, Sakarya Training and Research Hospital, Sakarya University, 54100 Sakarya, Türkiye.
  • Department of General Surgery, Faculty of Medicine, İstanbul Medipol University, 34403 Istanbul, Türkiye.
  • Department of Biochemistry, Faculty of Medicine, Istanbul Atlas University, 34403 Istanbul, Türkiye.

ORCID profiles: Emine Yildirim, Pelin Cobanoglu Akbas, Sibel Bektas, Adem Senturk, Pelin Basım, Umut Fırat Turan, Nesimi Mecit, Hanifi Onalan, Hafize Uzun, Mustafa Uygar Kalaycı

Cite

APA

Yildirim, E., Akbas, P. C., Bektas, S., Senturk, A., Basım, P., Turan, U. F., Mecit, N., Onalan, H., Uzun, H., & Kalaycı, M. U. (2026). Integrated Ultrasound Features, Cytologic Subclassification, and Systemic Inflammatory Markers for Predicting Malignancy in Bethesda III Thyroid Nodules. Journal of Clinical Medicine, 15(16), 6375. https://doi.org/10.3390/jcm15166375

Vancouver

Yildirim E, Akbas PC, Bektas S, Senturk A, Basım P, Turan UF, et al. Integrated Ultrasound Features, Cytologic Subclassification, and Systemic Inflammatory Markers for Predicting Malignancy in Bethesda III Thyroid Nodules. Journal of Clinical Medicine. 2026;15(16):6375. doi:10.3390/jcm15166375

BibTeX
@article{Yildirim2026,
  author = {Yildirim, Emine and Akbas, Pelin Cobanoglu and Bektas, Sibel and Senturk, Adem and Basım, Pelin and Turan, Umut Fırat and Mecit, Nesimi and Onalan, Hanifi and Uzun, Hafize and Kalaycı, Mustafa Uygar},
  title = {Integrated Ultrasound Features, Cytologic Subclassification, and Systemic Inflammatory Markers for Predicting Malignancy in Bethesda III Thyroid Nodules},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {16},
  pages = {6375},
  doi = {10.3390/jcm15166375}
}
Start for free →